Recombinant Human B-Gal/GLB1 Protein, C-His tag
- 
									
产品编号
KMH541
 - 
									
别名
β-半乳糖苷酶, EBP, ELNR1, MPS4B, galactosidase beta 1
 - 
									
规格
- 20ug
 - 50ug
 - 100ug
 - 200ug
 - 1mg
 
 
| Catalog Number | KMH541 | 
| Alias | β-半乳糖苷酶, EBP, ELNR1, MPS4B, galactosidase beta 1 | 
| Size | 20ug, 50ug, 100ug, 200ug, 1mg | 
| Product Description | KMH541 Recombinant Human B-Gal/GLB1 Protein, C-His tag contains the human GLB1(1-677 aa) was expressed in Mammalian cells. | 
| Molecular Name | GLB1 | 
| Product Introduction | GLB1 (KMH541) 参与糖类代谢,影响细胞内的糖代谢过程。 | 
| Molecular Weight | 70-95 kDa | 
| Expression System | CHO Cells | 
| Species | Human | 
| Concentration | 联系销售经理获得最新批次的浓度 | 
| Purity | ≥95% | 
| Purification | Affinity Purification | 
| Uniprot ID | P16278 | 
| Storage Condition | Store the product under sterile conditions after opening at -80℃ for 12 months. Store the lyophilized powder at -20℃. Avoid repeated freeze-thaw cycles. | 
| Formulation | PBS, pH7.5 | 
| Shipping Condition | This product is shipped on ice packs or dry ice. | 
| Background | Galactosidase is a lysosomal Galactosidase that hydrolyzes the terminal Galactose from Ganglioside and Keratan sulfate. In lysosome, the mature Galactosidase protein associates with Cathepsin A and Neuraminidase 1 to form the lysosomal multienzyme complex . An alternative splicing at the RNA level of Galactosidase results a catalytically inactive Galactosidase that plays an important role in vascular development. Defects of galactosidase (GLB1) are the cause of diseases like GM1-gangliosidosis which is a lysosomal storage disease and Morquio Syndrome B that cause patients to have abnormal elastic fibers. More than 1 mutations have been identified for Galactosidase, which result in different residual activities of the mutant enzymes and a spectrum of symptoms in the two related diseases. | 
| Endotoxin | < 0.1 EU per ug | 
| Protein Family | Other protein | 
| Biological Activity | Measured by its ability to cleave a fluorogenic substrate, 4- Methylumbelliferylbeta -Dgalactopyranoside. The specific activity is >1,800 pmol/min/μg, as measured underthe described conditions. | 
| Product Declaration | 该产品仅供科研使用,不可直接用于人体或注射。 | 
							
							
							
							
						
								0